
Ambr Institute
Medical platform leveraging explainable AI for personalized chronic disease prevention and management.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| Total Funding | 000k | ||
Related Content
Ambr operates in the healthcare sector, focusing on personalized and preventive medicine through its advanced medical platform. The company serves healthcare professionals and clinics, providing tools for real-time visualization of clinical data, precise disease probability assessments, and identification of key risk factors. By integrating explainable AI, Ambr ensures transparency in disease risk predictions, allowing physicians to understand the reasoning behind assessments and tailor interventions accordingly. The platform supports chronic disease management by designing follow-up plans and evidence-based, patient-tailored interventions. Ambr's business model likely involves partnerships with clinics and healthcare providers, generating revenue through subscriptions or service fees for its platform. The company is based in Oslo and emphasizes rigorous scientific collaboration to develop impactful medical software.
Keywords: healthcare, AI, chronic disease, prevention, personalized medicine, data analysis, bioinformatics, transparency, clinical data, risk assessment